Ontology highlight
ABSTRACT: SK-MEL-2 cells treated with Ad-E2F-1, Ad-E2F-1 plus doxorubicn or Ad-LacZ plus doxorubicin
PROVIDER: PRJNA92265 | ENA |
REPOSITORIES: ENA
ACCESS DATA